The majority of the patients had well-preserved synthetic function (eg, bilirubin and albumin), fewer than 15% had evidence of portal hypertension, and nearly 80% had early-stage HCC (BCLC-0 or BCLC-A). This evidence concerns the gene ALB and portal hypertension.